Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jong-Mu Sun

Showing results (91-100 of 303) with videos related to

Pageof 31
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 25, 2019
DNA Damage Response and Repair Pathway Alteration and Its Association With Tumor Mutation Burden and Platinum-Based Chemotherapy in SCLCSehhoon Park, Hayoon Lee, Boram Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|December 5, 2013
Clinical characteristics associated with ALK rearrangements in never-smokers with pulmonary adenocarcinomaJong-Mu Sun, Maruja Lira, Kinnari Pandya, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 13, 2020
Utility of positron emission-computed tomography for predicting pathological response in resectable oesophageal squamous cell carcinoma after neoadjuvant chemoradiationJiyun Lee, Joon Young Choi, Sung Won Lim, et al.
Translational Lung Cancer Research|December 3, 2021
Real-time autOmatically updated data warehOuse in healThcare (ROOT): an innovative and automated data collection systemHyun Ae Jung, Oksoon Jeong, Dong Kyung Chang, et al.
Cancer|March 11, 2020
Genomic landscape of acquired resistance to third-generation EGFR tyrosine kinase inhibitors in EGFR T790M-mutant non-small cell lung cancerJiyun Lee, Hong Sook Kim, Boram Lee, et al.
Cancer Research and Treatment|April 30, 2025
Clinical Relevance of Starting Alectinib at a Reduced Dose in Patients with ALK-Positive Non-Small Cell Lung CancerJunkyu Kim, Min-Ji Kim, Jinyong Kim, et al.
Cancer|January 2, 2024
Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune-related hepatitis in non-small cell lung cancer patients with chronic hepatitis BJoohyun Hong, Jiyun Lee, Sehhoon Park, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Repeat biopsy procedures and T790M rates after afatinib, gefitinib, or erlotinib therapy in patients with lung cancerKangkook Lee, Youjin Kim, Hyun Ae Jung, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 19, 2018
Transient Asymptomatic Pulmonary Opacities During Osimertinib Treatment and its Clinical ImplicationHansang Lee, Ho Yun Lee, Jong-Mu Sun, et al.
Japanese Journal of Clinical Oncology|October 28, 2008
Efficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancerJong-Mu Sun, Keun-Wook Lee, Jee Hyun Kim, et al.
Pageof 31

Showing results (91-100 of 303) with videos related to

Sort By:
Pageof 31
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 25, 2019
DNA Damage Response and Repair Pathway Alteration and Its Association With Tumor Mutation Burden and Platinum-Based Chemotherapy in SCLCSehhoon Park, Hayoon Lee, Boram Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|December 5, 2013
Clinical characteristics associated with ALK rearrangements in never-smokers with pulmonary adenocarcinomaJong-Mu Sun, Maruja Lira, Kinnari Pandya, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 13, 2020
Utility of positron emission-computed tomography for predicting pathological response in resectable oesophageal squamous cell carcinoma after neoadjuvant chemoradiationJiyun Lee, Joon Young Choi, Sung Won Lim, et al.
Translational Lung Cancer Research|December 3, 2021
Real-time autOmatically updated data warehOuse in healThcare (ROOT): an innovative and automated data collection systemHyun Ae Jung, Oksoon Jeong, Dong Kyung Chang, et al.
Cancer|March 11, 2020
Genomic landscape of acquired resistance to third-generation EGFR tyrosine kinase inhibitors in EGFR T790M-mutant non-small cell lung cancerJiyun Lee, Hong Sook Kim, Boram Lee, et al.
Cancer Research and Treatment|April 30, 2025
Clinical Relevance of Starting Alectinib at a Reduced Dose in Patients with ALK-Positive Non-Small Cell Lung CancerJunkyu Kim, Min-Ji Kim, Jinyong Kim, et al.
Cancer|January 2, 2024
Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune-related hepatitis in non-small cell lung cancer patients with chronic hepatitis BJoohyun Hong, Jiyun Lee, Sehhoon Park, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Repeat biopsy procedures and T790M rates after afatinib, gefitinib, or erlotinib therapy in patients with lung cancerKangkook Lee, Youjin Kim, Hyun Ae Jung, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 19, 2018
Transient Asymptomatic Pulmonary Opacities During Osimertinib Treatment and its Clinical ImplicationHansang Lee, Ho Yun Lee, Jong-Mu Sun, et al.
Japanese Journal of Clinical Oncology|October 28, 2008
Efficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancerJong-Mu Sun, Keun-Wook Lee, Jee Hyun Kim, et al.
Pageof 31